FOSUN HEALTH Logo

Laryngeal Cancer Treatment

catalogue

Laryngeal Cancer Treatment

Laryngeal Cancer Treatment

The treatment of laryngeal cancer is organised around one question before all others: can the larynx be kept? For an early tumour confined to the vocal cords the answer is usually yes, and a single treatment — an operation through the mouth or a course of radiotherapy — removes the cancer while leaving a working voice. For a tumour that has crossed into the cartilage or spread outside the larynx, the two routes have to be compared directly, because one of them involves removing the larynx and rebuilding the voice.

The route at each stage

The main fork in this disease is not between two drugs but between keeping the larynx and removing it — and the findings that decide it are established before treatment starts:

  • Early tumour confined to the cords (T1–T2, no nodes) — a single treatment: transoral laser microsurgery or radiotherapy. Both aim to clear the cancer and keep the voice, and the choice is made on the size and position of the tumour, the patient's general health, and what the voice needs to do afterwards.
  • Locally advanced tumour with a fixed cord or cartilage involvement (T3) — the two routes are placed side by side: surgery with post-operative radiotherapy, or chemoradiotherapy with the larynx preserved. The discussion turns on which gives the better chance of controlling the disease while leaving a larynx that functions.
  • Tumour through the cartilage or outside the larynx (T4) — removal of the whole larynx is usually the safer route, and the plan then includes the neck nodes and post-operative radiotherapy.
  • Nodes involved on one or both sides — treated as part of the same plan: neck dissection, radiotherapy to the neck, or both, depending on how many nodes and whether the tumour has grown beyond the node capsule.
  • Spread beyond the neck, or a tumour that cannot be removed — the aim becomes control of the disease rather than removal of the larynx, and systemic treatment takes the lead, with radiotherapy used for specific problems.

Early tumours: two single treatments, both aiming to preserve

When the tumour is confined to the cords, treatment is one modality rather than a combination, and the two options are genuinely alternatives:

  • Transoral laser microsurgery. The tumour is removed through the mouth with a laser and a microscope, with no incision in the neck. It is a single procedure, usually with a short stay, and the specimen can be examined to check the margins. Radiotherapy is then kept in reserve if it is needed later.
  • Radiotherapy. A course of daily treatment over several weeks, with no operation at all. It treats a defined volume rather than removing tissue, and it is preferred where the tumour is more extensive than the laser can reach with a safe margin, or where the patient's general health or preferences favour avoiding surgery.

Neither is generally superior, and the honest statement is that they work in different ways. The decision usually turns on the size and position of the tumour, how close it comes to the front of the vocal cord, what voice a given operation would leave, and what the patient is prepared to accept — an operation that recovers in a few days, or several weeks of daily radiotherapy with its own effects. Because the voice result weighs heavily here, a speech and language therapist takes part in the assessment before the choice is made, and can describe what each route usually leaves behind. That conversation, rather than a general preference for one technique, is what should settle the question.

Radiotherapy: what it involves and what it costs the patient

Radiotherapy is used in three different ways in this disease, and it is worth being clear which one is being discussed.

  • As the whole treatment for an early tumour, aiming to cure it while keeping the larynx intact.
  • After an operation, where the pathology shows features that raise the risk of recurrence — a close or involved margin, several involved nodes, or tumour that has grown beyond the node capsule.
  • Together with chemotherapy for locally advanced disease, as the organ-preservation route; and on its own, for specific problems such as bleeding or pain, where the aim is control rather than removal.

Its effects on the throat are cumulative and predictable. Soreness in the throat, a change in the voice, thickening of saliva, altered or lost taste, and tiredness build over the weeks of treatment and settle over the weeks after it, with dryness of the mouth often lasting longer. Swallowing can become uncomfortable enough that nutrition support is needed, which is why a dietitian and a speech and language therapist are part of the plan before treatment starts rather than a referral afterwards. Dental assessment comes first as well, because teeth in the treated area need attention before radiotherapy rather than after.

Surgery: partial and total laryngectomy

Operations on the larynx are described by how much is removed, and the distinction between them is the heart of the decision:

  • Transoral laser microsurgery — for early tumours, through the mouth, no incision in the neck, and the function of the larynx is largely kept.
  • Partial laryngectomy — removal of a part of the larynx, either through the neck or endoscopically, for selected tumours where the extent allows it. The voice is preserved in some form, and swallowing is usually retained, though the airway may need temporary protection while healing.
  • Total laryngectomy — removal of the whole larynx with the airway brought to a stoma at the front of the neck. Breathing is then through the stoma, permanently. The food pipe is untouched, so eating is usually normal again; speech has to be produced another way.
  • Neck dissection — removal of the lymph nodes at risk in the neck, carried out alongside the laryngeal surgery wherever nodes are involved, and sometimes electively on the side where spread is likely.
  • Tracheostomy — a temporary opening in the airway sometimes needed before or during treatment to secure breathing, which is a separate matter from a permanent stoma after laryngectomy.

A total laryngectomy is still necessary for functional reasons rather than surgical ambition. When the tumour has crossed the cartilage or has spread outside the larynx, it is often not possible to remove it with clear margins while leaving a larynx that can close off the airway and swallow safely. A larynx preserved but unable to protect the lungs is not preserved function. When the decision comes down to this, the patient has to be part of it — and has to hear from a therapist who does this every week what life with a stoma and a reconstructed voice is actually like.

Keeping the larynx: what it means and what it asks

Larynx preservation is a goal rather than a technique. It can be reached by surgery that removes only part of the larynx, by radiotherapy alone, or by chemoradiotherapy for a tumour that would otherwise need the whole larynx removed. What all three have in common is that the larynx remains in place and continues to produce sound.

It is not a free option, and the trade-offs should be stated plainly. A preserved larynx is rarely the voice it was: it is often lower, rougher, tiring, and quieter, and the patient may need to manage swallowing more consciously. Chemoradiotherapy in particular produces its effects over several weeks and has an aftermath that lasts longer still. And when organ preservation is chosen, salvage surgery remains available if the cancer recurs — but salvage after radiotherapy is a more demanding operation than a first operation would have been, which is part of what goes into the initial choice.

When preservation is not the right route, that is a clinical judgement rather than a failure. A patient whose lungs are compromised and whose larynx cannot protect the airway faces a real risk of repeated chest infection if the larynx is kept; a patient with a tumour that has crossed the cartilage may face a likelihood of incomplete clearance. In both situations, total laryngectomy with a planned programme of voice rehabilitation is the option that serves the patient better, and the discussion should say so clearly rather than presenting preservation as automatically preferable.

Drug treatment: where it is used

Drug treatment is not the mainstay of treating a laryngeal cancer that can be removed or irradiated, but it has defined roles that matter in particular situations.

  • Together with radiotherapy for locally advanced disease, as part of the organ-preservation route, where the cisplatin-based combination is used to make the radiotherapy more effective.
  • After surgery, with radiotherapy, where pathology findings indicate a higher risk of recurrence and the combination has been shown to be more effective than radiotherapy alone.
  • For recurrent or metastatic disease, where the aim is control. Immunotherapy with pembrolizumab is used where the tumour expresses PD-L1, cetuximab is used where immunotherapy is not suitable, and platinum-based chemotherapy combinations remain part of the options — sometimes continued after radiotherapy in selected patients.
  • For symptoms, and where a tumour cannot be treated with the aim of removal, drug treatment is combined with radiotherapy to control growth and relieve specific problems.

Voice, swallowing and the stoma

Rehabilitation is not an appendix to treatment here; it is the part that determines what daily life is like afterwards. It starts before treatment and continues through follow-up.

  • Speech and language therapy from the start. A baseline record of the voice and the swallow is taken before treatment, so that changes afterwards can be measured rather than guessed at.
  • Voice after total laryngectomy. Three routes exist — a tracheoesophageal speech valve placed in a small puncture between the airway and the food pipe, oesophageal speech, and an electrolarynx held against the neck. The valve gives the most natural-sounding voice for many patients and requires care and periodic replacement; the others suit different people and different anatomies. The choice is made with a therapist, not before.
  • Swallowing therapy. Exercises and techniques to protect the airway and to keep swallowing safe, which matter most after chemoradiotherapy and after partial laryngectomy.
  • Nutrition support. A dietitian works on texture, timing and intake through treatment and afterwards, and a feeding tube is used when it is needed rather than as a failure.
  • Stoma care. Humidification, cleaning, protection from water when bathing, and clear instructions for what to do if the stoma becomes blocked — taught before discharge, and revisited at follow-up.

How the plan is decided

The treatment of laryngeal cancer is decided at a multidisciplinary meeting, and in this disease that is not a formality. The two routes differ in what they do to the patient's voice, swallowing and breathing, so the meeting has to compare them rather than sequence them.

  • Head and neck surgery — whether the tumour can be removed with clear margins while keeping a functioning larynx, and which operation that would be.
  • Radiation oncology — whether radiotherapy would cover the tumour adequately, what volume would be treated, and what the effects on swallowing and saliva would be.
  • Medical oncology — whether drug treatment belongs in the first plan, and on what basis.
  • Radiology and pathology — reading the imaging and the tissue together, since the decision often turns on cartilage involvement and on margins rather than on the visible size of the tumour.
  • Speech and language therapy and nutrition — what each route would leave the patient with, described concretely, before the choice is made.

What the meeting needs from the patient is their priorities, stated plainly. How much the voice matters for work and for daily life; how they feel about a stoma; whether they would rather have one definitive treatment or accept a longer course with its own aftermath; how far they are able to travel for follow-up. Those considerations do not override the clinical findings, but they determine which of two reasonable routes is right for one person — and a plan that ignores them tends to be a plan that gets regretted. Ask for the recommendation to be written down with its reasoning, so that it can be reviewed rather than remembered.

Frequently Asked Questions

Which is better for an early tumour — laser surgery or radiotherapy?

Neither is better in general, and the honest answer is that they are alternatives that reach the same goal by different means. Laser surgery through the mouth is a single procedure with a short recovery, produces a specimen that can be checked for margins, and leaves radiotherapy in reserve for later if it is ever needed. Radiotherapy avoids an operation altogether but takes several weeks of daily treatment, with soreness, voice change and dry mouth that build up and then settle. The choice usually turns on the size and position of the tumour, how close it comes to the front of the cords, what the voice is likely to sound like afterwards, and what the patient would rather go through.

Will I be able to speak after a total laryngectomy?

Yes, but by another method, and the method is taught rather than assumed. The commonest is a tracheoesophageal speech valve — a small one-way valve placed in a puncture between the airway and the food pipe, which lets air from the lungs be used to produce voice. Oesophageal speech, using air taken into the food pipe, is another route, and an electrolarynx held against the neck is a third. Each has advantages and demands, and a speech and language therapist works with the patient to find the one that suits their anatomy and their life. Learning takes weeks of practice rather than days, and it happens with supervision.

What happens if I choose to keep the larynx and the cancer comes back?

Salvage surgery remains an option, and it is one of the reasons organ preservation is a defensible choice. If the cancer recurs after radiotherapy or after chemoradiotherapy, removing the larynx is usually still possible and can still control the disease. The important thing to know in advance is that a salvage operation after radiotherapy is more demanding than a first operation would have been — the tissues have been irradiated, healing is slower, and the rate of complications is higher. That is part of the comparison at the outset rather than a surprise afterwards, and it is a reason follow-up examinations after organ-preserving treatment are scheduled rather than left to symptoms.

How long is treatment, and how soon can I go home?

It depends entirely on the route. Transoral laser surgery is usually a short admission, with a return to normal eating over days and to normal activity within a couple of weeks. Partial laryngectomy involves a longer stay while the airway and the swallow recover, and total laryngectomy involves a stay measured in around a week to ten days, including training in stoma care and the beginning of voice rehabilitation. Radiotherapy as a single treatment runs over several weeks of daily attendance, and chemoradiotherapy over a similar period with additional monitoring. Ask for the estimate in phases — treatment, recovery, rehabilitation — rather than as one figure, because the recovery and the rehabilitation are the parts that determine when normal life resumes.

Compare the two routes before committing to one

Send the laryngoscopy images and report, the biopsy and pathology reports in full, the neck and chest imaging with reports and dates, the examination findings on vocal cord mobility, the operative and radiotherapy records if treatment has already been given, and a list of current medicines and other conditions. The international patient team returns a written assessment within 48 hours of the file being complete, with the two routes set out side by side where both are possible, and an itemised estimate on request.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*